Super Zhewitra Tablet embodies a pioneering approach targeted at countering male-specific sexual health predicaments, addressing two major sexual health problems—Erectile Dysfunction (ED) and Premature Ejaculation (PE). Comprising two key components, Vardenafil and Dapoxetine, Super Zhewitra Tablet acts as a potent dual-action treatment. Vardenafil categorizes as a type 5 phosphodiesterase inhibitor that combats ED by encouraging blood flow to instigate an erection. Concurrently, Dapoxetine, which classifies as an antidepressant under the selective serotonin reuptake inhibitor group, primarily navigates PE issues by delaying the climax.

Extra Super Zhewitra Tablet is a pharmaceutical agent developed to address erectile dysfunction (ED) issues and premature ejaculation. The dual-active components, Vardenafil and Dapoxetine, work in unison to tackle the challenges faced by men suffering from these sexual dysfunctions. Vardenafil is a PDE5 (Phosphodiesterase type 5) inhibitor widely recognized for its ability to aid in acquiring and maintaining an erection by increasing blood flow to the penis. Dapoxetine, a selective serotonin reuptake inhibitor (SSRI), primarily contributes to delaying ejaculation, hence combating premature ejaculation.